Diet and Motility in IBS

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

10 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

This study seeks to characterize dietary intake in children with IBS and explore severity of symptoms and quality of life. This study uses the G-Tech wireless patch system to define patterns of gut motility in patients with IBS and associate these patterns with dietary intake and GI symptoms. Participants will wear the patches for 7 days as a part of the study. They can be worn under clothing and participants can continue daily activities other than swimming, bathing (although they can shower), and exercising. Stool and urine samples will also be collected to explore the gut microbiome and its association with IBS symptoms, diet, and patterns of gut motility.

We are looking to partner with patients with a confirmed diagnosis of IBS between 8 and 18 years of age who are undergoing dietary modifications such as a low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) diet.

Who Do I Contact?

If you are interested in participating in the study or want to learn more please contact our study team at beniteza [at] chop.edu or 267-425-1937.

Eligibility & Criteria

IRB #:
22-020433
Official Title:
The Role of Diet and Gastrointestinal Motility in Irritable Bowel Syndrome (IBS)
Study Phase:
Pilot
Eligible Age Range:
8 - 18 Years
Gender:
All
Study Categories:

Visit Criteria

Participation consists of 1 in-person study visit followed by a 7-day monitoring period. During the 7-day monitoring period subjects will wear 3 wireless, adhesive patches on their abdomen that will measure gastrointestinal motility patterns; provide daily stool and urine samples that will be mailed to CHOP; answer questions about IBS symptoms and health using a phone app and online questionnaires; and provide information about foods eaten to a member of our team over the phone.

Subjects also complete several online questionnaires 4 weeks after the completion of the 7-day monitoring period. These questionnaires will ask about IBS symptoms and overall health.